Le Lézard
Classified in: Health, Science and technology, Business
Subjects: PDT, VEN

Aidéo Technologiestm, a Leading Provider of AI-Powered Medical Coding Workflow Productivity Tools, Announces Record Growth for Fiscal Year 2023


Significant advancements in Generative Artificial Intelligence (AI) for medical coding, specifically the integration of Large Language Models into the Gemini AutoCodetm solution along with enhancements to the Gemini Coder Platformtm fuels customer and partner expansion across multiple medical specialties.

PALM BEACH, Fla., Jan. 9, 2024 /PRNewswire/ -- Aidéo Technologies, a leading provider of AI-powered medical coding workflow productivity tools, announced today the achievement of banner growth in sales, data science and IT technology development for 2023.

During 2023, Aidéo integrated Large Language Models (LLMs) with its existing Machine Learning (ML) and Natural Language Processing (NLP) models to deploy and deliver Generative AI to the medical coding market. Along with customer-driven technology advancements to the Gemini Coder Platform, Aidéo deepened customer and partner relationships in the radiology, ambulatory surgical centers and emergency markets while fueling new growth into anesthesia, and urgent care and E/M (evaluation and management) coding for practice management settings.

"2023 was an important year in the evolution of Aidéo," said Raj Alva, Aidéo Chairman of the Board. "Integrating LLMs into our data science tech stack was a key advancement in bringing Generative AI to our solution. The revenue cycle expertise that our team leverages along with the technology we've developed is the combination that the medical coding marketing is seeking and we're looking forward to continuing our growth into 2024 and beyond."

Generative AI will allow Aidéo to continue to increase its pace of innovation by decreasing the amount of time to onboard new medical specialties, increasing the speed and frequency of model growth, and the ability to mitigate AI hallucinations and model drift.

"I'm pleased with the progress our team has made over the last year," said David Shelton, CEO of Aidéo. "The impact we've had with both our AI capabilities and the improvement we bring to medical coding operations has been substantial and well received. We are well poised to continue our growth trajectory."

Aidéo's Gemini Solutions Suitetm empowers medical coders through the combination of the Gemini Coder Platformtm and Gemini AutoCodetm solutions. The combination of the Aidéo platform and AI-driven coding allows for a collaboration between human medical coders and AI to continue to accelerate autonomous coding capabilities that drive cost reductions and productivity gains.

Aidéo Technologies

Aidéo Technologies is a leading provider of AI-powered medical coding productivity solutions to the revenue cycle management industry. Creating scalable and repeatable coding efficiency, Aidéo Technologies' Gemini Solution Suite empowers and complements medical coders with workflow efficiencies, artificial intelligence, and supplemental coding services. The Gemini Coder Platformtm, Gemini AutoCodetm, and Gemini Coding Assisttm solutions are optimized to work together for maximum impact in creating efficiency and improving accuracy through workflow improvements and autonomous and predictive coding. Aidéo is headquartered in Palm Beach, FL with locations in the San Francisco Bay area and Mumbai, India.

SOURCE Aideo Technology


These press releases may also interest you

at 10:45
eBlu Solutions, a leading provider of innovative technology solutions for the specialty healthcare industry, is pleased to announce the addition of Doug Lawrence to the Executive Leadership team in the role of Chief Revenue Officer. "We're not just...

at 09:18
NUVISTA Mental Health proudly announces its participation as a Gold Sponsor for the 2024 Ontario First...

at 09:05
Cardurion Pharmaceuticals, Inc. ("Cardurion"), a clinical-stage biotechnology company developing next-generation therapeutics for the treatment of cardiovascular diseases, today announced the presentation of positive clinical data from CARDINAL?HF,...

at 06:05
Dr. Majid Al Fayyadh, CEO of King Faisal Specialist Hospital and Research Centre (KFSH&RC) joined the Gulf Creatives Conference (GCC) at Harvard 2024. The event, GCC at Harvard, is organized by The Diwan, an organization run by graduate students at...

at 06:00
Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for use across a range of infectious disease, oncology,...

at 03:14
Caliway Biopharmaceuticals (Caliway) is pleased to announce its participation to share the latest clinical advancements at the upcoming 2024 BIO International Convention on Wednesday, June 5th, at 11:45 a.m. PDT. The presentation will take place in...



News published on and distributed by: